跳至主要内容
临床试验/ITMCTR2200005789
ITMCTR2200005789尚未招募1 期

Randomized, controlled and single center clinical trial of Jifafang in the treatment of acute exacerbation of chronic obstructive pulmonary disease

GuiZhou University of traditiongal Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 80(—)
性别
All

入选标准

  • 1.Meet the diagnostic criteria of western medicine for acute exacerbation of chronic obstructive pulmonary disease according to the guidline of GOLD in 2022;
  • 2.Hospitalized patients by emergency department with acute exacerbation within 3 days;
  • 3.with age between 18 and 80 years old;
  • 4.Agree to sign informed consent.

排除标准

  • 1.Patients who require invasive mechanical ventilation;
  • 2.Complicated with a severe tumor, unstable coronary heart disease, abnormal liver and kidney function, cerebrovascular accident, and other diseases;
  • 3.Those with known or suspected history of alcohol or drug abuse;
  • 4.Patients with mental disorders who are unable to actively cooperate with treatment;
  • 5.Patients with severe intellectual or cognitive impairments;?
  • 6.Patients with a history of allergies to related drugs.?
  • 7.Those who have participated in other clinical trials within the past 3 months;
  • 8.Those who are judged by the investigator to be unsuitable to participate in this clinical trial.

研究者

发起方
GuiZhou University of traditiongal Chinese Medicine

相似试验